Cyanotech Corporation (Nasdaq: CYAN) announced today that its industry-leading product, BioAstin® Natural Astaxanthin, has obtained self-affirmed GRAS status (Generally Recognized As Safe for use in food and beverage applications) by a panel of experts assembled by GRAS Associates, LLC. GRAS assessment documentation has been submitted to the US Food & Drug Administration (FDA) for the agency’s review. “Cyanotech is pleased to have BioAstin self-affirmed with GRAS status, which will allow manufacturers to use it in a variety of functional food and beverage products,” said Gerald R. Cysewski, Ph.D., Cyanotech’s Founder and Chief Scientific Officer. “BioAstin is used as a stand-alone nutritional supplement or in supplement formulas in over 50 countries worldwide.” All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers.
